about
Drugs acting on SUR1 to treat CNS ischemia and traumaNewly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic strokeThe aminoguanidine carboxylate BVT.12777 activates ATP-sensitive K+ channels in the rat insulinoma cell line, CRI-G1ATP-sensitive potassium channel (KATP channel) expression in the normal canine pancreas and in canine insulinomas.Apoptosis in pancreatic β-islet cells in Type 2 diabetesHypoglycemic agents and potential anti-inflammatory activityPancreatic regulation of glucose homeostasisDiabetes mellitus and renal failure: Prevention and managementMolecular pathophysiology of cerebral edemaMolecular action of sulphonylureas on KATP channels: a real partnership between drugs and nucleotidesPlace of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementClinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combinationAn NBD Derivative of the Selective Rat Toxicant Norbormide as a New Probe for Living Cell ImagingPractical combination therapy based on pathophysiology of type 2 diabetesDual role of proapoptotic BAD in insulin secretion and beta cell survivalHuman genetics as a model for target validation: finding new therapies for diabetes.Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus ManagementGenetics of Type 2 Diabetes: the Power of Isolated Populations.Vesicular nucleotide transporter-mediated ATP release regulates insulin secretion.Optimal therapy of type 2 diabetes: a controversial challengeRemote control of glucose homeostasis in vivo using photopharmacology.β-Cell Replacement Strategies: The Increasing Need for a "β-Cell Dogma".Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets.Effect of an isolated active compound (Cg-1) of Cassia glauca leaf on blood glucose, lipid profile, and atherogenic index in diabetic rats.Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissuesPersistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implicationsThe molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetesThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesOptical control of insulin release using a photoswitchable sulfonylureaAge-related mitochondrial DNA depletion and the impact on pancreatic Beta cell function.Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes riskAssessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin-sulfonylurea combination: Results of a multicenter, cross-sectional, observational study in KoreaPharmacogenomics of cardiovascular complications in diabetes and obesity.Novel human ABCC9/SUR2 brain-expressed transcripts and an eQTL relevant to hippocampal sclerosis of agingDecreases in Gap Junction Coupling Recovers Ca2+ and Insulin Secretion in Neonatal Diabetes Mellitus, Dependent on Beta Cell Heterogeneity and NoiseIncreased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus.Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident strokeA review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetesOverexpression of a glucokinase point mutant in the treatment of diabetes mellitusAmplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K(+) channel opener?
P2860
Q24655850-0677F7BD-0FBB-4D74-B074-3B53963300C0Q24657830-84B9FD25-B7CC-4DEC-A5C0-BAA0EB91987DQ24806328-7FE2E354-4212-4624-BE1C-1E93D8EDD526Q24811899-EF6C04F4-B1EA-47DD-85C8-A47AFEA8CCFAQ26747141-61997E71-7401-462D-B256-DB0F94D1F27DQ26750414-408E3E5A-E2E5-477A-AD65-84E0995C0450Q26766485-A7FD6FFD-84F8-4BDF-89FA-D772143B2B0AQ26768488-5637453B-FF99-4F7D-B970-E6E8817E323BQ26776371-6BC6D75D-D756-4290-A8AC-5D5FD675407EQ26777728-20525473-FB28-40B0-A57C-C2A541FFE32BQ26783199-3DEC2777-AC72-49EA-83FA-7DEA94981CA8Q27026211-F43C85E5-97FE-44D3-B663-24EB6F38A524Q27308015-ADCA573A-9740-4416-AAB2-B05CE7B504FAQ28076530-F05869C3-CAEC-413D-818F-C95F1949692DQ28586275-A4356BCD-F52D-43BE-AD37-345DCD21208FQ30234640-9EFEA2A2-957B-4975-9485-E7CA3EC6E926Q30238519-2611E612-6123-401B-BFB8-A639FCA9961FQ30250281-9AB05A30-DEED-4C98-B1B8-1DBD4B2354CAQ30414996-05B81770-8016-4CC9-9BBB-188944D3101CQ33577712-3546F1A0-91CD-4CC3-B790-6F054F3CF518Q33670713-39FAF4B2-C62C-465B-B661-58B295A4C3FDQ33766081-CD01D421-DAE0-411C-82AE-12BD6A118F0AQ33825190-E4A1F616-82C2-418C-A2C8-F9FC79FEE011Q33874050-581636F4-7BBF-406F-B919-2C3E10D3C7EDQ34042814-FC718D24-48D6-4388-A899-5B3BCB4CD0C2Q34104226-4D028466-2EA1-405A-A58F-B122C8219B63Q34316689-379A787D-DDD9-4E88-AB56-E6F078E9CDE4Q34329204-B0E9703A-8D5F-4E67-9918-C9EA61D2DF71Q34397447-ECEEBCFF-9775-444C-A0FD-D66728933C33Q34756967-D5FBC75E-B38B-4BC9-B232-7426773B5682Q35220562-722A68DE-C2FF-4D47-B6E3-5B4136DDB141Q35571835-00655448-3389-4C59-8F61-51582C73552BQ35647167-D7648BA1-5352-4176-8B04-AD63D4DA87DCQ36121718-202D44A3-03A2-43E4-BE5F-6A6E1FF79C3EQ36146862-C25D1EAC-B3B4-41C6-AFA1-EE4110EBAFF9Q36456052-A7077892-D235-436C-AFE4-2F397578CEEFQ36520595-4BB062DE-2F5A-40D7-ABA7-3C8E61A01789Q36536205-99AA6D71-C0AD-440E-BF9A-5A53B8B40671Q36785004-0A61290B-E0B2-4D29-B8B0-CF51ED47A8D8Q36975491-A23EC575-7509-4C26-AFB0-5BB99B0AEC3A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Sulfonylurea stimulation of insulin secretion.
@ast
Sulfonylurea stimulation of insulin secretion.
@en
Sulfonylurea stimulation of insulin secretion.
@nl
type
label
Sulfonylurea stimulation of insulin secretion.
@ast
Sulfonylurea stimulation of insulin secretion.
@en
Sulfonylurea stimulation of insulin secretion.
@nl
prefLabel
Sulfonylurea stimulation of insulin secretion.
@ast
Sulfonylurea stimulation of insulin secretion.
@en
Sulfonylurea stimulation of insulin secretion.
@nl
P2093
P1433
P1476
Sulfonylurea stimulation of insulin secretion.
@en
P2093
Fiona Gribble
Frances Ashcroft
Frank Reimann
Nick Green
Peter Proks
P304
P356
10.2337/DIABETES.51.2007.S368
P407
P478
51 Suppl 3
P577
2002-12-01T00:00:00Z